asinex        CONTACTS               SITE MAP              F.A.Q.                НOME PAGE
 
  




  • News
  • Press Releases
  • Upcoming events





  • News / Press Releases /

    October, 2003

    ASINEX announces successful Lead Optimization project with Asahi Kasei


    Moscow, October 2003 - ASINEX, a leading European provider of Lead Generation and Optimization services and products, today announce the signing of a lead optimization project with Asahi Kasei, one of Japan's leading pharmaceutical companies.

    ASINEX are performing optimization of a hit compound provided by Asahi Kasei at their facilities in Moscow. Several rounds of synthesis have already been successfully completed, and options for further optimization are being explored.

    Dr.Hiroyuki Kouji, General Manager, Laboratory for Medicinal Chemistry, Asahi Kasei said, "This collaboration with ASINEX has been a significant benefit to our research efforts at Asahi Kasei. Through our collaboration we were able to identify a number of new lead compounds of therapeutic interest in a short period of time. We are very happy with the skill and talents of ASINEX's scientists, and believe their cost-effectiveness and reliability puts them well ahead of their competition. Asahi Kasei is looking forward to enjoying a long and fruitful collaboration with ASINEX."

    Dr Dimitri Genis, Director of Research at ASINEX commented "We have great respect for Asahi Kasei as one of the leading Japanese pharmaceutical companies. We are delighted to be providing chemical services for Asahi Kasei. It is a high priority for us to establish the service chemistry business of ASINEX in Asia. We look forward to the successful completion of our project and would look forward to continued work with Asahi Kasei in the future"

    About ASINEX

    ASINEX (www.asinex.com) is a full-service chemistry provider of 'Intelligent Chemistry` for the lead generation and optimization stage of drug discovery. Well known as a supplier of diverse, small molecule libraries for screening and building blocks for combinatorial chemistry, ASINEX has developed a reputation for cost-effective and efficient Lead Optimization, Custom Synthesis and Focused Library Generation. Based in Moscow, with a total of 104 chemists (41 PhDs), 8 computational (6 PhDs) chemists and 17 biologists (11 PhDs), ASINEX has powerful drug discovery resources.

    About Asahi Kasei

    Asahi Kasei (www.asahi-kasei.co.jp) is a US$10 billion technology company, whose mission is to provide innovative, science-based solutions, contributing to greater quality of life. Its health care business activities include the discovery, development, manufacture and marketing of pharmaceutical products, as well as the development, manufacture and marketing of diagnostic reagents and filtration products. Asahi Kasei is headquartered in Tokyo, Japan.

    For more info please contact:

    ASINEX Ltd
    Alistair Melvin
    Business Development Officer
    Tel: (00)7 495 780 3411
    Fax: (00)7 495 780 3419
    Email: amelvin@asinex.com

     

     

     

    About | News | Products | Services | Online Feedback

    © 1994-2005 ASINEX, All rights reserved